KalVista Pharmaceuticals
KALV
KALV
183 hedge funds and large institutions have $1.39B invested in KalVista Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 63 increasing their positions, 45 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% more capital invested
Capital invested by funds: $1.08B → $1.39B (+$313M)
14% more funds holding
Funds holding: 161 → 183 (+22)
2.77% more ownership
Funds ownership: 132.43% → 135.2% (+2.8%)
Holders
183
Holding in Top 10
9
Calls
$39.1M
Puts
$21.2M
Top Buyers
| 1 | +$9.09M | |
| 2 | +$8.22M | |
| 3 | +$7.24M | |
| 4 |
AC
Armistice Capital
New York
|
+$7.03M |
| 5 |
CCM
Catalio Capital Management
New York
|
+$6.87M |
Top Sellers
| 1 | -$15.9M | |
| 2 | -$10.7M | |
| 3 | -$6.63M | |
| 4 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$5.68M |
| 5 |
O
OrbiMed
New York
|
-$4.64M |
